Bifocal Transcranial Alternating Current Stimulation Targeting the Frontoparietal Network in Stroke Patients

NCT ID: NCT06809959

Last Updated: 2025-02-13

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 20 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-02-03
• Study Completion Date: 2026-08-31

Brief Summary

Hand and arm function is often significantly impaired in stroke patients, making its recovery a primary goal in rehabilitative treatment. This study investigates the effects of bifocal transcranial alternating current stimulation (tACS) on the frontoparietal network in stroke patients during the subacute to chronic recovery phase. By using non-invasive brain stimulation, the study aims to modulate the neural network connectivity between the ipsilesional parietal and premotor cortices. Electroencephalography and kinematic data will be utilized to assess the impact of tACS on functional connectivity and its subsequent effect on motor function. The ultimate goal is to enhance functional coupling within these networks to promote motor function in stroke patients.

Detailed Description

Hand and arm function is often significantly impaired in stroke patients, making recovery of these functions a primary goal in stroke rehabilitation. Despite advances in acute stroke thera-pies, more than 50% of stroke survivors continue to experience motor deficits, particularly in hand and arm function, which negatively impacts their quality of life. The integrity of neural networks, especially the frontoparietal network, plays a central role in motor control, and has been shown to be altered after stroke. Transcranial alternating current stimulation (tACS) offers a promis-ing approach to modulate these brain network connections, potentially influencing motor func-tion in stroke patients.

In a randomized, controlled, triple-blind, crossover design, this study investigates the effects of 24Hz bifocal tACS on functional connectivity between the ipsilesional anterior intraparietal sulcus (aIPS) and ventral premotor cortex (PMv) in stroke patients during the subacute to chronic recovery phase. Each patient will receive three types of stimulation-(i) in-phase tACS, (ii) out-of-phase tACS, and (iii) sham stimulation-in a randomized order, with a one-week washout pe-riod between sessions to avoid carryover effects. During in-phase tACS, 24Hz stimulation over aIPS and PMv will be in phase; during out-of-phase stimulation, the phase across sights will vary by 180 degrees.

Bifocal tACS will be delivered using two four-electrode montages centered over the aIPS and PMv of the lesioned hemisphere for approximately 21 minutes per session. During each session, patients will perform a Reach-to-Grasp (RTG) task three times: before stimulation, during stimu-lation, and after stimulation. Patients will perform both a pinch grip and a whole-hand grasp during the RTG task. EEG data will be collected pre- and post-stimulation, while kinematic meas-urements will also be recorded during the stimulation task. To minimize skin sensations under the electrodes and improve blinding, a local anesthetic consisting of lidocaine and prilocaine will be applied prior to electrode placement. Clinical assessments as well as structural and func-tional imaging will be obtained to characterize each patient.

The investigators hypothesize that 24Hz bifocal tACS on the frontoparietal network alters its connectivity compared to sham stimulation.

This study seeks to enhance the understanding of functional coupling within the frontoparietal network, aiming to establish bifocal tACS as a targeted and innovative therapy to improve motor function in stroke patients.

Conditions

Stroke; Hand Functions; Cerebrovascular Disease; Brain Diseases

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: CROSSOVER
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: TRIPLE

Study Groups

In-phase-tACS

Patients will perform a reach-to-grasp task with their affected hand during bifocal tACS targeting the aIPS and PMv of the lesioned hemisphere during three seperat sessions. The sequence of stimulation types will be randomized.

Group Type: ACTIVE_COMPARATOR

In-phase-tACS

Intervention Type: DEVICE

21 minutes and 30 seconds of bifocal stimulation at 3 mA peak-to-peak per field, targeting the aIPS and PMv of the lesioned hemisphere. The stimulation is delivered at 24 Hz with the waveforms of both fields aligned in phase. A 10-second ramp-up at the beginning and a 10-second ramp-down at the end are included to ensure participant comfort. The protocol is administered using the Starstim® device with gel-based electrodes, each with a π cm² surface area.

Out-of-phase-tACS

Patients will perform a reach-to-grasp task with their affected hand during bifocal tACS targeting the aIPS and PMv of the lesioned hemisphere during three seperat sessions. The sequence of stimulation types will be randomized.

Group Type: ACTIVE_COMPARATOR

Out-of-phase-tACS

Intervention Type: DEVICE

21 minutes and 30 seconds of bifocal stimulation at 3 mA peak-to-peak per field over the aIPS and PMv of the lesioned hemisphere at 24 Hz. In this condition, the waveforms of the two fields are shifted by 180°, creating an out-of-phase stimulation pattern. A 10-second ramp-up and ramp-down are included, and the protocol is administered using the Starstim® device with gel-based electrodes, each with a π cm² surface area.

Sham -tACS

Patients will perform a reach-to-grasp task with their affected hand during bifocal tACS targeting the aIPS and PMv of the lesioned hemisphere during three seperat sessions. The sequence of stimulation types will be randomized.

Group Type: SHAM_COMPARATOR

Sham -tACS

Intervention Type: DEVICE

21 minutes and 30 seconds of stimulation mimicking the setup of active tACS, with an initial 10-second ramp-up followed by a 10-second ramp-down. The remainder of the session is stimulation-free. This protocol is administered using the Starstim® device and gel-based electrodes with a π cm² surface area, maintaining the same setup as the active conditions to ensure comparability.

Interventions

In-phase-tACS

21 minutes and 30 seconds of bifocal stimulation at 3 mA peak-to-peak per field, targeting the aIPS and PMv of the lesioned hemisphere. The stimulation is delivered at 24 Hz with the waveforms of both fields aligned in phase. A 10-second ramp-up at the beginning and a 10-second ramp-down at the end are included to ensure participant comfort. The protocol is administered using the Starstim® device with gel-based electrodes, each with a π cm² surface area.

Intervention Type: DEVICE

Out-of-phase-tACS

21 minutes and 30 seconds of bifocal stimulation at 3 mA peak-to-peak per field over the aIPS and PMv of the lesioned hemisphere at 24 Hz. In this condition, the waveforms of the two fields are shifted by 180°, creating an out-of-phase stimulation pattern. A 10-second ramp-up and ramp-down are included, and the protocol is administered using the Starstim® device with gel-based electrodes, each with a π cm² surface area.

Intervention Type: DEVICE

Sham -tACS

21 minutes and 30 seconds of stimulation mimicking the setup of active tACS, with an initial 10-second ramp-up followed by a 10-second ramp-down. The remainder of the session is stimulation-free. This protocol is administered using the Starstim® device and gel-based electrodes with a π cm² surface area, maintaining the same setup as the active conditions to ensure comparability.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• First-ever clinical stroke
• Signed informed consent
• First-ever clinical ischemic stroke at least 3 months ago
• Stimulation areas (PMv and IPS) are unaffected
• Residual deficits in the upper limb

Exclusion Criteria

• Presence of additional neurological or psychiatric disorders
• Use of psychotropic medication
• Pregnancy or potential pregnancy in female participants
• Pacemakers, other stimulators, or medication pumps
• Claustrophobia
• Non-MRI-compatible metallic implants or foreign objects in the body
• Contraindications for transcranial alternating current stimulation (e.g., epilepsy, history of seizures, any type of pacemaker)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Technical University of Twente

OTHER

Sponsor Role: collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

Sponsor Role: lead

Responsible Party

Fanny Quandt

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Fanny Quandt, Dr. med.

Role: PRINCIPAL_INVESTIGATOR

Deparment of Neurology, University Medical Center Hamburg-Eppendorf

Robert Schulz, PD Dr. med.

Role: PRINCIPAL_INVESTIGATOR

Deparment of Neurology, University Medical Center Hamburg-Eppendorf

Locations

Department of Neurology, University Medical Center Hamburg-Eppendorf

Hamburg, , Germany

Site Status: RECRUITING

Countries

Germany

Central Contacts

Fanny Quandt, Dr. med.

Role: CONTACT

f.quandt@uke.de

+4974100

Robert Schulz, PD Dr. med.

Role: CONTACT

r.schulz@uke.de

+4974100

Facility Contacts

Fanny Quandt, Dr.med.

Role: primary

f.quandt@uke.de

+4974100

Other Identifiers

biTACS

Identifier Type: -

Identifier Source: org_study_id